Spironolactone (SP) is an effective treatment for polycystic ovary syndrome (PCOS), but it is often associated with menstrual abnormalities whose mechanism is still under investigation. In this study, we investigated the serum sex steroids and endometrial thickness in 30 PCOS patients, before and after one-month 100 mg SP treatment.
Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI
SABBADIN, CHIARA;ANDRISANI, ALESSANDRA;ZERMIANI, MONICA;DONA', GABRIELLA;BORDIN, LUCIANA;RAGAZZI, EUGENIO;BOSCARO, MARCO;AMBROSINI, GUIDO;ARMANINI, DECIO
2016
Abstract
Spironolactone (SP) is an effective treatment for polycystic ovary syndrome (PCOS), but it is often associated with menstrual abnormalities whose mechanism is still under investigation. In this study, we investigated the serum sex steroids and endometrial thickness in 30 PCOS patients, before and after one-month 100 mg SP treatment.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
